Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
Add more filters

Publication year range
1.
Rapid Commun Mass Spectrom ; 35(10): e9067, 2021 May 30.
Article in English | MEDLINE | ID: mdl-33656207

ABSTRACT

RATIONALE: Recently, new psychoactive substances (NPS) have emerged as a public health risk. Particularly, their chemical structures are modified to avoid detection. Synthetic NPS with effects similar to those of illegal drugs have been recently detected and synthesized worldwide, including MDMB-FUBINACA and APINAC, making it essential to rapidly and accurately detect NPS. METHODS: Fourteen NPS with similar structures were selected and their structures identified using 1 H and 13 C NMR spectroscopy. Additionally, we proposed the fragmentation pattern of each compound using liquid chromatography/quadrupole time-of-flight mass spectrometry (LC/QTOF-MS). A simultaneous analytical method using liquid chromatography/electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) was also developed and applied to real samples to detect the 14 NPS. The method was validated based on the specificity, linearity, limit of detection (LOD), limit of quantification (LOQ), precision, accuracy, matrix effect, and stability according to international validation guidelines. RESULTS: The established method was used to screen 65 different matrix samples using LC/ESI-MS/MS. By comparing the calculated product ion ratios with those of standards, 2C-B in one of the real samples and 5F-MDMB-PICA in 20 samples were identified. For re-confirmation of detected compounds, the fragmentation pattern of each compound was compared with that of each standard using LC/QTOF-MS. CONCLUSIONS: In this study, LC/QTOF-MS data were used to elucidate the structures and fragmentation patterns of 14 NPS. A simultaneous method was developed using LC/ESI-MS/MS, which was applied to 65 real samples. The presented method and results can assist in ensuring the safety of public health from illegal adulteration.


Subject(s)
Chromatography, Liquid/methods , Psychotropic Drugs/chemistry , Tandem Mass Spectrometry/methods , Adamantane/analogs & derivatives , Adamantane/analysis , Cannabinoids/analysis , Drug Contamination , Indazoles/analysis , Limit of Detection , Spectrometry, Mass, Electrospray Ionization/methods
2.
Environ Geochem Health ; 41(2): 817-828, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30225731

ABSTRACT

The composition and physical properties of spilled oil have great changes during the seriously weathering process. It brings great difficulties to the source identification of oil spill. So the stable and trustworthy diagnostic ratios (DRs) for accurate identification of severely weathered spilled oils are very important. The explosion of Sinopec pipeline happened on November 22, 2013 at Qingdao, China. Local beaches at Jiaozhou Bay were polluted by spilled oils. We have collected original spilled oil samples from an area free from human interference near the oil leakage point after the accident. Synchronized with actual beach weathering, laboratory experiments were conducted to simulate oil weathering for 360 days by using the collected original spilled oil samples. Based on t test and the repeatability limit method, 50 diagnostic ratios (DRs) of adamantanes were screened. Four DRs, namely 1,3-dimethyladamantane/total dimethyladamantane, 1-methyladamantane/(1-methyladamantane + 1,3-dimethyladamantane), dialkyl diamantane/total diamantane, and diamantane/(diamantane + dialkyl diamantane), have maintained remarkable stability during the simulated weathering experiments and field weathering process. These stable ratios can retain the characteristics of oil source during weathering. They are very beneficial to improve the accuracy of identifying the source of severely weathered oil and can be used as an effective supplement to existing index system for source identification.


Subject(s)
Adamantane/analysis , Environmental Pollutants/analysis , Oils/analysis , Petroleum Pollution/analysis , China , Petroleum/analysis , Weather
3.
J Sep Sci ; 41(19): 3764-3771, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30063122

ABSTRACT

In-capillary derivatization using fluorescamine as the labeling reagent was proposed to enhance the detectability of adamantine drugs (memantine, amantadine and rimantadine) by spectrophotometric detection. Fluorescamine and the drugs were delivered to the capillary electrophoresis instrument at a ratio of 10:1 by zone injection. The derivatization reaction occurred following the application of voltage (20 kV). The derivatized products, hydrolyzed- fluorescamine and excess fluorescamine were separated in 7 min using 100 mM borate buffer (pH 10.0) containing 0.1% w/v of Brij®-35 and 20% v/v of acetonitrile. Validation data showed good linearity (r2  > 0.98), precision (%RSDs < 3.4), and accuracy (recoveries ranging from 98.0 to 102.0%). The detection and quantitation limits are in the range of 6.0-8.5 and 18-25 µM, respectively. The validation data is comparable to reported methods, however, the current method offers better precision with enhanced sensitivity (up to six times). Applications of the method show percent labeled amounts found in the studied samples within 100.6-109.3%, which complied with the United States Pharmacopeia limit (90.0-110.0%). The method was simple, rapid and, automated, which required no extra instrumentation or skillful operators.


Subject(s)
Adamantane/analysis , Fluorescamine/chemistry , Electrophoresis, Capillary , Molecular Structure , Spectrophotometry, Ultraviolet
4.
J Sep Sci ; 40(5): 1184-1192, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28087893

ABSTRACT

Brompheniramine, an antihistamine drug, was employed as a novel UV probe for capillary electrophoresis with indirect UV detection of adamantane drugs (memantine, amantadine, and rimantadine). The probe possesses high molar absorptivity of 24 × 103 L/mol cm at 6 mM, which enables the measurement of these nonchromophore analytes without derivatization. The simple background electrolyte (10 mM sodium dihydrogen phosphate (pH 5.0) containing 5 mM brompheniramine and 6 mM ß-cyclodextrin) provided the separation of the analytes in a short time (7.5 min). Under these conditions, brompheniramine had similar mobility to that of the analyte ions resulting in symmetric peaks with minimal electrodispersion. The analytes displace the probe at a one-to-one ratio with transfer values close to unity. ß-Cyclodextrin played a role in the resolution of the structurally similar adamantane derivatives. Method validation showed good linearity (r2  > 0.98), precision (%RSD ≤ 3.30), and accuracy (recoveries ranging from 98 to 109%). The proposed method was successfully applied to determine the adamantane content in pharmaceutical products.


Subject(s)
Adamantane/analysis , Brompheniramine/chemistry , Electrophoresis, Capillary , Rimantadine/analysis , Electrolytes
5.
Bioorg Med Chem ; 24(24): 6348-6353, 2016 12 15.
Article in English | MEDLINE | ID: mdl-27134119

ABSTRACT

The platensimycin (PTM) and platencin (PTN) class of natural products are promising drug leads that target bacterial and mammalian fatty acid synthases. Natural congeners and synthetic analogues of PTM and PTN have been instrumental in determining their structure-activity relationships, with only a few analogues retaining the potencies of PTM and PTN. Here we describe the identification and isolation of two new sulfur-containing PTM congeners (3 and 5) from the engineered dual PTM-PTN overproducing Streptomyces platensis SB12029. Structure elucidation of platensimycin D1 (5), a sulfur-containing PTM pseudo-dimer, revealed the existence of its presumptive thioacid precursor (3). The unstable thioacid 3 was isolated and confirmed by structural characterization of its permethylated product (6). LC-MS analysis of crude extracts of SB12029 confirmed the presence of the thioacid analogue of PTN (4). The minimum inhibitory concentration (MIC) was determined for 5 revealing retention of the strong antibacterial activity of PTM.


Subject(s)
Adamantane/pharmacology , Aminobenzoates/pharmacology , Aminophenols/pharmacology , Anilides/pharmacology , Anti-Bacterial Agents/pharmacology , Biological Products/pharmacology , Polycyclic Compounds/pharmacology , Streptomyces/chemistry , Sulfur/pharmacology , Adamantane/analysis , Aminobenzoates/analysis , Aminophenols/analysis , Anilides/analysis , Anti-Bacterial Agents/analysis , Biological Products/analysis , Microbial Sensitivity Tests , Micrococcus luteus/drug effects , Polycyclic Compounds/analysis , Staphylococcus aureus/drug effects , Sulfur/analysis
6.
J Am Chem Soc ; 137(28): 8908-11, 2015 Jul 22.
Article in English | MEDLINE | ID: mdl-26160008

ABSTRACT

Fluorescence-based single-vesicle fusion assays provide a powerful method for studying mechanisms underlying complex biological processes of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor)-mediated vesicle fusion and neurotransmitter release. A crucial element of these assays is the ability of the fluorescent probe(s) to reliably detect key intermediate events of fusion pore opening and content release/mixing. Here, we report a new, reliable, and efficient single-vesicle content-mixing assay using a high affinity, fluorophore tagged host-guest pair, cucurbit[7]uril-Cy3 and adamantane-Cy5 as a fluorescence resonance energy transfer (FRET) pair. The power of these probes is demonstrated by the first successful observation of flickering dynamics of the fusion pore by in vitro assay using neuronal SNARE-reconstituted vesicles.


Subject(s)
Fluorescence Resonance Energy Transfer/methods , Fluorescent Dyes/analysis , Membrane Fusion , SNARE Proteins/metabolism , Adamantane/analysis , Adamantane/metabolism , Animals , Bridged-Ring Compounds/analysis , Bridged-Ring Compounds/metabolism , Carbocyanines/analysis , Carbocyanines/metabolism , Fluorescent Dyes/metabolism , Humans , Imidazoles/analysis , Imidazoles/metabolism , Neurons/metabolism , SNARE Proteins/analysis
8.
Biomed Chromatogr ; 28(12): 1722-7, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24771661

ABSTRACT

A novel LC-MS/MS method was developed for the quantification of vildagliptin in an aqueous matrix. The method was successfully validated, meeting all the requisites of US Food and Drug Administration guide for a bioanalytical method. The developed method presented a limit of quantification of 10 ng/mL and the range of concentration achieved was 10-1875 ng/mL. The injection volume necessary was only 10 µL, and retention time was 4.60 min. The mobile phase employed was methanol-ammonium acetate 5 mm (95:5). The stability of the drug was evaluated in the different conditions through which the samples passed. A pharmacokinetic experiment was conducted with diabetic male Wistar rats, and the concentration of drug in liver was evaluated through a microdialysis technique. The perfusion fluid employed was ultrapure water. The dose administrated was 50 mg/kg and the method allowed the quantification of vildagliptin for more than three half lives, successfully characterizing the pharmacokinetic profile when the developed method was applied. This is the first report on the tissue pharmacokinetics of a DPP-4 inhibitor and could contribute to drug dosage optimization in the future.


Subject(s)
Adamantane/analogs & derivatives , Chromatography, High Pressure Liquid/methods , Diabetes Mellitus, Experimental/metabolism , Microdialysis/methods , Nitriles/analysis , Pyrrolidines/analysis , Adamantane/analysis , Adamantane/chemistry , Adamantane/pharmacokinetics , Animals , Dipeptidyl-Peptidase IV Inhibitors/analysis , Dipeptidyl-Peptidase IV Inhibitors/chemistry , Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics , Drug Stability , Liver/chemistry , Male , Muscles/chemistry , Nitriles/chemistry , Nitriles/pharmacokinetics , Pyrrolidines/chemistry , Pyrrolidines/pharmacokinetics , Rats , Rats, Wistar , Reproducibility of Results , Sensitivity and Specificity , Tandem Mass Spectrometry/methods , Tissue Distribution , Vildagliptin
9.
Pharmazie ; 69(2): 86-91, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24640595

ABSTRACT

A stability-indicating capillary zone electrophoresis (CZE) method was validated for the determination of vildagliptin (VLG) in pharmaceutical dosage forms using ranitidine hydrochloride (RH) as internal standard. The CZE method was carried out in a fused silica capillary (64.5 cm total length and 56.0 cm effective length, 50 microm i.d.) by applying a potential of 25 kV (positive polarity), hydrodynamic injection by 50 mbar for 5 s and the temperature of the capillary cartridge was 25 degreesC. The selected background electrolyte (BGE) consisted of 25 mM potassium phosphate (pH 8.0) with UV/PDA detection at 207 nm. The electrophoretic separation was obtained within 6 min and was linear in the range of 50-200 microg/mL (r= 0.9994). The specificity and the stability-indicating capability were demonstrated through degradation studies, which also showed that there was no interference of the formulation excipients. The method was validated in accordance to ICH guidelines acceptance criteria for specificity, linearity, precision, accuracy, robustness and system suitability. The proposed method was compared with HPLC method previously validated for this drug, and statistical analysis showed no significant difference between the methods.


Subject(s)
Adamantane/analogs & derivatives , Dipeptidyl-Peptidase IV Inhibitors/analysis , Nitriles/analysis , Pyrrolidines/analysis , Adamantane/analysis , Chemistry, Pharmaceutical , Chromatography, High Pressure Liquid , Electrophoresis, Capillary , Indicators and Reagents , Limit of Detection , Reference Standards , Reproducibility of Results , Solutions , Tablets , Vildagliptin
10.
Drug Dev Ind Pharm ; 39(5): 657-61, 2013 May.
Article in English | MEDLINE | ID: mdl-22568696

ABSTRACT

A simple and sensitive extractive spectrophotometric method have been developed and validated for determination of amantadine hydrochloride (AM), memantine hydrochloride (MM) and rimantadine hydrochloride (RM) in pure and pharmaceutical formulations. The method is based on the reaction of these active compounds with bromophenol blue (BB) in acetate buffer (0.1 M) pH 3.5 to form an orange-colored products which have absorption maxima at 408 nm. The procedure of complexation was optimized with regard to such factors as concentrations of BB, pH of medium, a kind of extracting solvents and a number of extractions. Under the optimum conditions, linear relationships A408 = f(c) with good correlation coefficients (≥0.996) and low limit of detection were obtained in the ranges of 50.0-220.0 µg·mL(-1), 20.0-150.0 µg·mL(-1) or 10.0-110.0 µg·mL(-1) for AM, MM and RM, respectively, for the spectrophotometric methods. The proposed method could be applied to the determination of AM, MM and RM in dosage forms. The recovery was 95.3-101.9%. The method was linear, precise and accurate.


Subject(s)
Adamantane/analysis , Bromphenol Blue/chemistry , Pharmaceutical Preparations/chemistry , Spectrophotometry, Ultraviolet/methods , Indicators and Reagents/chemistry , Limit of Detection
11.
Int J Mol Sci ; 13(9): 11399-11410, 2012.
Article in English | MEDLINE | ID: mdl-23109861

ABSTRACT

Diamondoids in crude oil are useful for assessing the maturity of oil in high maturation. However, they are very difficult to separate and accurately quantify by conventional geochemical methods due to their low abundance in oil. In this paper, we use comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry (GC×GC-TOFMS) to study the compounds in condensates from the Junggar Basin of northwest China and address their geological and geochemical applications. GC×GC-TOFMS improves the resolution and separation efficiency of the compounds. It not only separates the compounds that coelute in conventional GC-MS (e.g., 4, 8-dimethyl-diamantane and trimethyl-diamantane) but also allows the identification of compounds that were not previously detected (e.g., trimethyl-diamantane (15A)). A reversed-phase column system improves the separation capabilities over the normal phase column system. The diamondoid indexes indicate that a representative condensate from Well DX 10 is highly mature with equivalent Ro being approximately 1.5%.


Subject(s)
Adamantane/analysis , Alkanes/analysis , Diamond/analysis , Geologic Sediments/analysis , Alkanes/chemistry , China , Chromatography, Gas , Diamond/chemistry , Petroleum/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
12.
Diabetes Metab Syndr ; 16(3): 102437, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35255292

ABSTRACT

BACKGROUND AND AIMS: This study aimed to assess the effects of vildagliptin on the prevention of cardiovascular diseases in Thai patients with type 2 diabetes mellitus using the Thai Cardiovascular Risk Score. METHODS: All patients with type 2 diabetes mellitus who used vildagliptin at a secondary hospital in Thailand were screened and recruited. The relevant variables were obtained from patient medication charts at the first visit on which the patients were prescribed vildagliptin and from the 6-month, 12-month, and 18-month post-treatment visits. The Thai Cardiovascular Risk Score was calculated and monitored as a primary outcome, whereas changes in separate cardiometabolic parameters were assessed as secondary outcomes. RESULTS: Of the 321 patients screened, only 95 were recruited for the analysis. The average 10-year cardiovascular risks of patients increased from 19.65% at baseline to 20.74%, 20.69%, and 23.78% at 6, 12, and 18 months post treatment, respectively. However, a better trend of reduction in cardiovascular risk was observed in patients with a high baseline cardiovascular risk. The glucose-lowering effects of vildagliptin were significantly observed 12 months of treatment onwards, but non-significant changes were found in lipid and blood pressure levels as well as body mass index. CONCLUSION: Vildagliptin provided a promising glucose-lowering effect in Thai patients with type 2 diabetes mellitus. However, the mean 10-year cardiovascular risk did not significantly decrease. However, a negative correlation between cardiovascular risk reduction and baseline cardiovascular risk was observed in this study. Low sample size was a major limitation of this study.


Subject(s)
Adamantane , Cardiovascular Diseases , Diabetes Mellitus, Type 2 , Dipeptidyl-Peptidase IV Inhibitors , Adamantane/analysis , Adamantane/therapeutic use , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Cardiovascular Diseases/prevention & control , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Dipeptidyl-Peptidase IV Inhibitors/therapeutic use , Glycated Hemoglobin/analysis , Heart Disease Risk Factors , Humans , Hypoglycemic Agents/therapeutic use , Nitriles/therapeutic use , Risk Factors , Thailand/epidemiology , Treatment Outcome , Vildagliptin/adverse effects
13.
J Org Chem ; 75(1): 102-16, 2010 Jan 01.
Article in English | MEDLINE | ID: mdl-19957924

ABSTRACT

Hydroxymethylphenols strategically substituted with the 2-hydroxy-2-adamantyl moiety, AdPh 8-10, were synthesized, and their photochemical reactivity was investigated. On excitation to the singlet excited state, AdPh 8 undergoes intramolecular proton transfer coupled with a loss of H(2)O giving quinone methide 8QM. The presence of 8QM has been detected by laser flash photolysis (CH(3)CN-H(2)O 1:1, tau = 0.55 s) and UV-vis spectroscopy. Singlet excited states of AdPh 9 and 10 in the presence of H(2)O dehydrate giving 9QM and 10QM. Photochemically formed QMs are trapped by nucleophiles giving the addition products (e.g., Phi for methanolysis of 8 is 0.55). In addition, the zwitterionic 9QM undergoes an unexpected rearrangement involving transformation of the 2-phenyl-2-adamantyl cation into the 4-phenyl-2-adamantyl cation (Phi approximately 0.03). An analogous rearrangement was observed with methoxy derivatives 9a and 10a. Zwitterionic 9QM was characterized by LFP in 2,2,2-trifluoroethanol (tau = 1 mus). In TFE, in the ground state, AdPh 10 is in equilibrium with 10QM, which allowed for recording the (1)H and (13)C NMR spectra of the QM. Introduction of the adamantyl substituent into the o-hydroxymethylphenol moiety increased the quantum yield of the associated QM formation by up to 3-fold and significantly prolonged their lifetimes. Furthermore, adamantyl substituent made the study of the alkyl-substituted quinone methides easier by LFP by prolonging their lifetimes and increasing the quantum yields of formation.


Subject(s)
Adamantane/chemistry , Indolequinones/chemistry , Quinones/chemistry , Adamantane/analysis , Adamantane/chemical synthesis , Animals , Catalysis , Cations/chemistry , Indolequinones/analysis , Lasers , Light , Magnetic Resonance Spectroscopy , Mice , Molecular Structure , Photochemistry , Photolysis , Spectrophotometry, Ultraviolet
15.
Cell Biol Toxicol ; 25(3): 217-25, 2009 Jun.
Article in English | MEDLINE | ID: mdl-18386137

ABSTRACT

Cisplatin is a highly effective chemotherapeutic agent against many tumors; however, it is also a potent nephrotoxicant. Given that there have been no significant advances in our ability to clinically manage acute renal failure since the advent of dialysis, the development of novel strategies to ablate nephrotoxicity would represent a significant development. In this study, we investigated the ability of an inhibitor of soluble epoxide hydrolase (sEH), n-butyl ester of 12-(3-adamantan-1-yl-ureiido)-dodecanoic acid (nbAUDA), to attenuate cisplatin-induced nephrotoxicity. nbAUDA is quickly converted to AUDA and results in maintenance of high AUDA levels in vivo. Subcutaneous administration of 40 mg/kg of nbAUDA to C3H mice every 24 h resulted in elevated blood levels of AUDA; this protocol was also associated with attenuation of nephrotoxicity induced by cisplatin (intraperitoneal injection) as assessed by BUN levels and histological evaluation of kidneys. This is the first report of the use of sEH inhibitors to protect against acute nephrotoxicity and suggests a therapeutic potential of these compounds.


Subject(s)
Adamantane/analogs & derivatives , Antineoplastic Agents/toxicity , Cisplatin/toxicity , Enzyme Inhibitors/pharmacology , Epoxide Hydrolases/antagonists & inhibitors , Kidney Diseases/chemically induced , Lauric Acids/pharmacology , Adamantane/analysis , Adamantane/metabolism , Adamantane/pharmacokinetics , Adamantane/pharmacology , Adamantane/toxicity , Animals , Blood Urea Nitrogen , Chromatography, High Pressure Liquid , Drug Antagonism , Enzyme Inhibitors/pharmacokinetics , Injections, Subcutaneous , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Kidney Diseases/metabolism , Lauric Acids/analysis , Lauric Acids/metabolism , Lauric Acids/pharmacokinetics , Male , Mice , Mice, Inbred C3H , Microsomes, Liver/drug effects , Microsomes, Liver/metabolism , Rats , Spectrometry, Mass, Electrospray Ionization , Tandem Mass Spectrometry
16.
J Chromatogr A ; 1605: 460368, 2019 Nov 08.
Article in English | MEDLINE | ID: mdl-31353073

ABSTRACT

Comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry (GC × GC-TOFMS) is a powerful instrument for the analysis of complex samples. Deconvolution of overlapped analytes using a suitable chemometric data analysis method such as Parallel Factor Analysis (PARAFAC) is often required. However, PARAFAC is designed to require a strict data trilinearity requirement. In this study we examine how strict this requirement is in the context of GC × GC experimental conditions, and demonstrate that under suitable conditions the data is sufficiently trilinear to achieve accurate deconvolution. The term trilinear deviation ratio (TDR) was previously introduced as a quantitative metric to predict the accuracy of PARAFAC deconvolution. Trilinear deviation ratio is defined as the run-to-run retention time shift, Δ2tR, for a given analyte on the second dimension (2D) separation, divided by the 2D analyte peak width-at-base, 2Wb. We demonstrate that experimental conditions impact the TDR range produced and PARAFAC performance. Column selection and modulation period, PM, are shown to significantly influence the TDR range. Two column sets were evaluated, giving rise to different k' ranges for the 2D separations. Each column set was used with an optimum PM as well as a longer PM to demonstrate the effect of PM selection on the TDR range and PARAFAC quantification. A PM of 6 s produced a Δ2tR range from -19.5 ms to -98 ms and TDRs from 0.157 to 0.439, translating into a PARAFAC bias from +1.6% to -13.5%. However, a PM of 1.5 s produced a Δ2tR range of -1.1 ms to -8.8 ms, and significantly lower TDRs from 0.013 to 0.057, translating into PARAFAC errors from +2.1% to -3.9%, with an average of -1.1% ± 1.4. These results validate the idea that a suitable GC × GC experimental design will provide accurate quantification with PARAFAC.


Subject(s)
Factor Analysis, Statistical , Gas Chromatography-Mass Spectrometry/methods , Adamantane/analysis
17.
Spectrochim Acta A Mol Biomol Spectrosc ; 222: 117120, 2019 Nov 05.
Article in English | MEDLINE | ID: mdl-31252262

ABSTRACT

Dapagliflozin (DPF) and saxagliptin (SXG) are currently co-formulated in a tablet dosage form which is prescribed to improve glycemic control. The absorption spectra of DPF and SXG were highly overlapped which completely hindered their simultaneous estimation at their λmax 224 nm and 209 nm, respectively. Thus, in this work three smart and simple univariate spectrophotometric methods were originally established and validated for the first time in order to quantitatively estimate DPF and SXG in bulk forms and in combined pharmaceutical formulation without the requirement for any initial separation or treatment. These methods are; factorized zero order method (FZM), factorized derivative method (FDM) and factorized ratio difference method (FRM). These methods were capable of determining DPF and SXG over the range of 2.5-50.0 µg/mL and 2.5-60.0 µg/mL, respectively. All the developed methods are based on a novel and unique approach for the spectral recovery of unresolved spectra named; factorized response spectrum (FRS). The exclusivity of the FRS originates from its ability to completely resolve the cited drugs in the mixture and retrieve their original spectra. Selectivity of all proposed methods was assessed by comparing the obtained results of the mixture analysis with those of the pure powdered drugs. Validation of the newly developed methods was applied as recommended by the ICH demonstrating acceptable accuracy and precision. In general, these methods could be effectively employed for the routine quality control investigation of bulk materials and available market formulations.


Subject(s)
Adamantane/analogs & derivatives , Benzhydryl Compounds/analysis , Dipeptides/analysis , Dipeptidyl-Peptidase IV Inhibitors/analysis , Glucosides/analysis , Sodium-Glucose Transporter 2 Inhibitors/analysis , Adamantane/analysis , Drug Combinations , Limit of Detection , Spectrophotometry/methods , Tablets
18.
Anticancer Agents Med Chem ; 19(4): 463-472, 2019.
Article in English | MEDLINE | ID: mdl-30523770

ABSTRACT

BACKGROUND AND OBJECTIVE: The DNA repair enzyme tyrosyl-DNA-phosphodiesterase 1 (TDP1) is a current inhibition target to improve the efficacy of cancer chemotherapy. Previous studies showed that compounds combining adamantane and monoterpenoid fragments are active against TDP1 enzyme. This investigation is focused on the synthesis of monoterpenoid derived esters of 1-adamantane carboxylic acid as TDP1 inhibitors. METHODS: New esters were synthesized by the interaction between 1-adamantane carboxylic acid chloride and monoterpenoid alcohols. The esters were tested against TDP1 and its binding to the enzyme was modeling. RESULTS: 13 Novel ester-based TDP1 inhibitors were synthesized with yields of 21-94%; of these, nine esters had not been previously described. A number of the esters were found to inhibit TDP1, with IC50 values ranging from 0.86-4.08 µM. Molecular modelling against the TDP1 crystal structure showed a good fit of the active esters in the catalytic pocket, explaining their potency. A non-toxic dose of ester, containing a 3,7- dimethyloctanol fragment, was found to enhance the cytotoxic effect of topotecan, a clinically used anti-cancer drug, against the human lung adenocarcinoma cell line A549. CONCLUSION: The esters synthesized were found to be active against TDP1 in the lower micromolar concentration range, with these findings being corroborated by molecular modeling. Simultaneous action of the ester synthesized from 3,7-dimethyloctanol-1 and topotecan revealed a synergistic effect.


Subject(s)
Adamantane/analysis , DNA Repair , Monoterpenes/analysis , Phosphodiesterase Inhibitors/pharmacology , Phosphoric Diester Hydrolases/drug effects , Catalytic Domain , Cell Line, Tumor , Drug Screening Assays, Antitumor , Humans , Models, Molecular , Phosphodiesterase Inhibitors/chemistry , Phosphoric Diester Hydrolases/chemistry , Phosphoric Diester Hydrolases/metabolism , Spectrum Analysis/methods
19.
Article in English | MEDLINE | ID: mdl-29549742

ABSTRACT

The main analytical targets of synthetic cannabinoids are often metabolites. With the high number of new psychoactive substances entering the market, suitable workflows are needed for analytical target identification in biological samples. The aims of this study were to identify the main metabolites of the synthetic cannabinoids, AMB-CHMICA and 5C-AKB48, using an in silico-assisted workflow with analytical data acquired using ultra-high-performance liquid chromatography-(ion mobility spectroscopy)-high resolution-mass spectrometry in data-independent acquisition mode (UHPLC-(IMS)-HR-MSE). The metabolites were identified after incubation with rat and pooled human hepatocytes using UHPLC-HR-MSE, followed by UHPLC-IMS-HR-MSE. Metabolites of AMB-CHMICA and 5C-AKB48 were predicted with Meteor (Lhasa Ltd) and imported to the UNIFI software (Waters). The predicted metabolites were assigned to analytical components supported by the UNIFI in silico fragmentation tool. The main metabolic pathway of AMB-CHMICA was O-demethylation and hydroxylation of the methylhexyl moiety. For 5C-AKB48, the main metabolic pathways were hydroxylation(s) of the adamantyl moiety and oxidative dechlorination with subsequent oxidation to the ω-COOH. The matrix components in the metabolite spectra were reduced with IMS, which improved the accuracy of the spectral interpretation; however, this left fewer fragment ions for assigning sites of metabolism. Meteor was able to predict the majority of the metabolites, with the most notable exception being the oxidative dechlorination and, consequently, all metabolites that underwent that transformation pathway. Oxidative dechlorination of ω-chloroalkanes in humans has not been previously reported in the literature. The postulated metabolites can be used for screening of biological samples, with four-dimensional identification based on retention time, collision cross section, precursor ion, and fragment ions.


Subject(s)
Cannabinoids/metabolism , Chromatography, High Pressure Liquid/methods , Hepatocytes/metabolism , Illicit Drugs/metabolism , Adamantane/analysis , Adamantane/chemistry , Adamantane/metabolism , Animals , Cannabinoids/analysis , Cannabinoids/chemistry , Humans , Illicit Drugs/analysis , Illicit Drugs/chemistry , Indoles/analysis , Indoles/chemistry , Indoles/metabolism , Mass Spectrometry/methods , Rats
20.
Drug Test Anal ; 9(2): 248-255, 2017 Feb.
Article in English | MEDLINE | ID: mdl-26968728

ABSTRACT

This paper reports analytical properties of three cannabimimetic indazole and pyrazole derivatives seized from a clandestine laboratory. These three new synthetic cannabinoids include N-(1-adamantyl)-2-pentyl-2H-indazole-3-carboxamide (APINACA 2H-indazole analogue, 1), N-(1-adamantyl)-4-methyl-1-pentyl-5-phenyl-1H-pyrazole-3-carboxamide (AMPPPCA, 2), and N-(1-adamantyl)-1-(5-fluoropentyl)-4-methyl-5-phenyl-1H-pyrazole-3-carboxamide (5F-AMPPPCA, 3). These compounds were identified by liquid chromatography-quadrupole time-of-flight-mass spectrometry (LC-QTOF-MS), gas chromatography-time-of-flight-mass spectrometry (GC-TOF-MS), and nuclear magnetic resonance (NMR) spectroscopy. No analytical properties and pharmacological activities about compounds 1-3 have appeared until now, making this the first report on these compounds. Copyright © 2016 John Wiley & Sons, Ltd.


Subject(s)
Adamantane/analogs & derivatives , Cannabinoids/analysis , Illicit Drugs/analysis , Indazoles/analysis , Psychotropic Drugs/analysis , Pyrazoles/analysis , Adamantane/analysis , Chromatography, Liquid , Gas Chromatography-Mass Spectrometry , Magnetic Resonance Spectroscopy , Mass Spectrometry
SELECTION OF CITATIONS
SEARCH DETAIL